Alimera Sciences Stock Analysis

Alimera Stock Analysis Notes

About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Alimera Sciences was presently reported as 0.88. The company recorded a loss per share of 0.84. Alimera Sciences last dividend was issued on the 15th of November 2019. The entity had 1:15 split on the 15th of November 2019. Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 145 people. For more info on Alimera Sciences please contact Daniel Myers at 678 990 5740 or go to https://alimerasciences.com.

Alimera Sciences Investment Alerts

Alimera Sciences Upcoming and Recent Events

Alimera Largest EPS Surprises

View All Earnings Estimates

Alimera Stock Institutional Investors

Note, although Alimera Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Alimera Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 187.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alimera Sciences's market, we take the total number of its shares issued and multiply it by Alimera Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Alimera Profitablity

The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.

Management Efficiency

Alimera Sciences has return on total asset (ROA) of (0.0123) % which means that it has lost $0.0123 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5876) %, meaning that it created substantial loss on money invested by shareholders. Alimera Sciences' management efficiency ratios could be used to measure how well Alimera Sciences manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to drop to -0.38. In addition to that, Return On Capital Employed is likely to drop to -0.01. At this time, Alimera Sciences' Asset Turnover is very stable compared to the past year.

Technical Drivers

As of the 24th of April, Alimera Sciences shows the Standard Deviation of 3.21, risk adjusted performance of (0.01), and Mean Deviation of 2.33. Alimera Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for Alimera Sciences, which can be compared to its peers. Please confirm Alimera Sciences coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and skewness to decide if Alimera Sciences is priced correctly, providing market reflects its regular price of 3.63 per share. Given that Alimera Sciences has information ratio of (0.06), we suggest you to validate Alimera Sciences's prevailing market performance to make sure the company can sustain itself at a future point.

Alimera Sciences Price Movement Analysis

Alimera Sciences Insider Trading Activities

Alimera Sciences Predictive Daily Indicators

Alimera Sciences Corporate Filings

Alimera Sciences Forecast Models

Alimera Sciences' time-series forecasting models are one of many Alimera Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alimera Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Alimera Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alimera shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Alimera Sciences. By using and applying Alimera Stock analysis, traders can create a robust methodology for identifying Alimera entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Alimera analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Alimera analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Alimera Sciences stock analysis indicators help investors evaluate how Alimera Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Alimera Sciences shares will generate the highest return on investment. By understating and applying Alimera Sciences stock analysis, traders can identify Alimera Sciences position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.

Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.